E. Greenbaum

发表

Local and systemic immune response in community‐dwelling elderly after intranasal or intramuscular immunization with inactivated influenza vaccine

Y. Friedlander, A. B. Yehuda, M. Schein, 2000, Journal of medical virology.

Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine.

M. Muszkat, G. Friedman, Z. Zakay‐Rones, 2003, Vaccine.

Immunogenicity and safety of a novel IL-2-supplemented liposomal influenza vaccine (INFLUSOME-VAC) in nursing-home residents.

Y. Barenholz, Aviva Joseph, E. Kedar, 2003, Vaccine.

Local SIgA response following administration of a novel intranasal inactivated influenza virus vaccine in community residing elderly.

A. B. Yehuda, M. Schein, P. Naveh, 2000, Vaccine.

A double-blind trial of a new inactivated, trivalent, intra-nasal anti-influenza vaccine in general practice: relationship between immunogenicity and respiratory morbidity over the winter of 1997-98.

A. Morag, Z. Zakay‐Rones, A. Kiderman, 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine.

D. Engelhard, A. Morag, Z. Zakay‐Rones, 2004, Vaccine.

Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti‐influenza vaccine *

A. Morag, Z. Zakay‐Rones, A. Kiderman, 2001, Journal of medical virology.

A summer outbreak of influenza A virus infection among young children.

D. Wolf, E. Kerem, A. Hay, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains.

Y. Barenholz, S. Samira, E. Kedar, 2001, Vaccine.

Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1

Angel Porgador, J. Hanna, H. Achdout, 2006, Nature Immunology.

Isolation of Influenza C Virus during an Outbreak of Influenza A and B Viruses

A. Morag, Z. Zakay‐Rones, E. Greenbaum, 1998, Journal of Clinical Microbiology.

Emergence of oseltamivir-resistant influenza A/H3N2 virus with altered hemagglutination pattern in a hematopoietic stem cell transplant recipient.

D. Wolf, L. Cohen-Daniel, Z. Zakay‐Rones, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.

Z. Zakay‐Rones, E. Greenbaum, G. Muhamed, 2006, The Israel Medical Association journal : IMAJ.

Immunogenicity and safety of a novel liposomal influenza subunit vaccine (INFLUSOME‐VAC) in young adults

Y. Barenholz, Aviva Joseph, E. Kedar, 2003, Journal of medical virology.

Mucosal [SIgA] and serum [IgG] immunologic responses in the community after a single intra-nasal immunization with a new inactivated trivalent influenza vaccine.

A. Morag, Z. Zakay‐Rones, A. Kiderman, 2002, Vaccine.

Severe influenza infection in a chronic hepatitis C carrier: failure of protective serum HI antibodies after IM vaccination.

T. Ben-Hur, Z. Zakay‐Rones, R. Nir-Paz, 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.